Oaktree Acquisition Corp. III Life Sciences Warrant (OACCW) Stock Price

OACCWStock

$0.95

Market Cap—

P/E—

PEG Ratio—

Div yield—

Beta—

OACCW Share Price Chart

Favorite Metrics

Price vs S&P 500 (4W)12.92%

VGM Score65.93

Industry Peers — Blank Checks / SPACs(917)

Symbol	Value Score	Growth Score	Momentum Score	Price
OACCWOaktree Acquisition Corp. III Life Sciences Warrant	—	—	B	$0.95
DMIIDrugs Made In America Acquisition II Corp. Ordinary Shares	—	—	C	$10.14
EVACEQV Ventures Acquisition Corp. II	—	—	B	$10.30
CXIIChurchill Capital Corp XII Class A Ordinary Shares	—	—	A	$10.83
BCSSBain Capital GSS Investment Corp.	—	—	C	$10.28
CEPFCantor Equity Partners IV, Inc. Class A Ordinary Shares	—	—	C	$10.36
AEXAAmerican Exceptionalism Acquisition Corp. A	—	—	C	$11.50
DBCAD. Boral Acquisition I Corp. Class A Ordinary Shares	—	—	C	$10.00
GHXIGores Holdings XI, Inc. Class A Ordinary Shares	—	—	C	$9.97
GCGRGeneral Catalyst Global Resilience Merger Corp. Class A Ordinary Shares	—	—	C	$10.18
NWAXNew America Acquisition I Corp.	—	—	C	$10.19
MEVOM Evo Global Acquisition Corp II Class A Ordinary Shares	—	—	B	$10.01
KRSPRice Acquisition Corporation 3	—	—	B	$10.67
GTENGores Holdings X, Inc. Class A ordinary shares	—	—	B	$10.68
GIWGigCapital8 Corp. Class A Ordinary Shares	F	—	C	$10.15
ANSCAgriculture & Natural Solutions Acquisition Corporation Class A Ordinary Shares	D	C	C	$11.46
CRANCrane Harbor Acquisition Corp. II Class A Ordinary Shares	—	—	B	$10.14
RFAIURF Acquisition Corp II Unit	D	F	A	$47.01
APXTApex Treasury Corporation Class A Ordinary Share	—	—	C	$10.12
KBONKarbon Capital Partners Corp. Class A Ordinary Shares	—	—	C	$10.12
IEAGInfinite Eagle Acquisition Corp. Class A Ordinary Shares	—	—	C	$10.22
MBVIM3-Brigade Acquisition VI Corp. Class A Ordinary Shares	—	—	C	$10.21
IACOIdea Acquisition Corp. Class A Ordinary Shares	—	—	C	$9.99
MESHMeshflow Acquisition Corp. Class A Ordinary Shares	—	—	B	$10.08
RFAIRF Acquisition Corp II Ordinary Shares	D	F	A	$52.05
TLNCTalon Capital Corp. Class A Ordinary Shares	—	—	C	$10.22
KRAQKRAKacquisition Corp Class A Ordinary Shares	—	—	C	$9.98
PTORPraetorian Acquisition Corp. Class A Ordinary Shares	—	—	C	$9.99
KFIIK&F Growth Acquisition Corp. II Class A Ordinary shares	—	B	C	$10.64
BCCQBleichroeder Acquisition Corp. III Class A Ordinary Shares	—	—	A	$10.04
XRPNArmada Acquisition Corp. II Class A Ordinary Shares	F	—	C	$10.55
CLBRColombier Acquisition Corp. III	—	F	B	$10.24
OSPROsprey Acquisition Corp. III Class A Ordinary Shares	—	—	D	$9.85
CRAQCal Redwood Acquisition Corp. Class A Ordinary Shares	—	—	B	$10.36
NPACNew Providence Acquisition Corp. III Class A Ordinary Shares	—	—	C	$10.44
MBAVM3-Brigade Acquisition V Corp. Class A Ordinary shares	—	D	D	$11.14
RTACRenatus Tactical Acquisition Corp I Class A Ordinary Shares	—	—	C	$10.45
SAAQSpace Asset Acquisition Corp. Class A Ordinary Shares	—	—	C	$10.13
TACOBerto Acquisition Corp. Ordinary Shares	—	—	C	$10.48
PCAPProCap Acquisition Corp Class A Ordinary Shares	—	—	C	$10.36
ZKPLafayette Digital Acquisition Corp. I Class A Ordinary Shares	—	—	C	$10.02
GUACBerto Acquisition Corp. II Ordinary Shares	—	—	D	$9.95
MTALMetals Acquisition Corp. II	A	A	C	$10.20
ALFCenturion Acquisition Corp. Class A Ordinary Shares	C	B	C	$10.88
RDAGRepublic Digital Acquisition Company Class A Ordinary Shares	—	—	C	$10.40
WENNWen Acquisition Corp Class A Ordinary Shares	C	—	B	$10.39
CCCTColumbus Circle Capital Corp III Class A Ordinary Shares	—	—	D	$9.83
YICCYorkville International Capital Corp. Class A Ordinary Shares	—	—	B	$9.93
KEYYKeystone Acquisition Corp. Class A Ordinary Shares	—	—	C	$9.90
HACQHCM IV Acquisition Corp. Class A Ordinary Share	—	—	C	$10.06
BBCQBleichroeder Acquisition Corp. II Class A Ordinary Shares	—	—	A	$9.79

About Oaktree Acquisition Corp. III Life Sciences Warrant

Oaktree Acquisition Corp III Life Sciences is a special purpose acquisition company (SPAC) created to identify and acquire a life sciences business. As a blank check company, it operates without a predetermined merger target, offering investors potential exposure to opportunities within the life sciences sector. The company's returns depend on successfully completing a merger or acquisition with a suitable operating company.